311 related articles for article (PubMed ID: 28550192)
1. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study.
van Es N; Di Nisio M; Cesarman G; Kleinjan A; Otten HM; Mahé I; Wilts IT; Twint DC; Porreca E; Arrieta O; Stépanian A; Smit K; De Tursi M; Bleker SM; Bossuyt PM; Nieuwland R; Kamphuisen PW; Büller HR
Haematologica; 2017 Sep; 102(9):1494-1501. PubMed ID: 28550192
[TBL] [Abstract][Full Text] [Related]
2. Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients.
Di Nisio M; van Es N; Rotunno L; Anzoletti N; Falcone L; De Tursi M; Natoli C; Tinari N; Cavallo I; Valeriani E; Candeloro M; Guglielmi MD; Rutjes AWS; Porreca E
J Thromb Thrombolysis; 2019 Jul; 48(1):125-133. PubMed ID: 30919253
[TBL] [Abstract][Full Text] [Related]
3. Comparison among three predictive models for cancer-associated thromboembolism in a hispanic population.
Ramos-Esquivel A; Marenco-Flores A; Hernández-Romero G; Céspedes-Calvo A; Mora-Hidalgo R
J Thromb Thrombolysis; 2023 Oct; 56(3):433-438. PubMed ID: 37407771
[TBL] [Abstract][Full Text] [Related]
4. The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer.
van Es N; Franke VF; Middeldorp S; Wilmink JW; Büller HR
Thromb Res; 2017 Feb; 150():30-32. PubMed ID: 28002757
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer.
Guman NAM; van Geffen RJ; Mulder FI; van Haaps TF; Hovsepjan V; Labots M; Cirkel GA; Y F L de Vos F; Ten Tije AJ; Beerepoot LV; Tjan-Heijnen VCG; van Laarhoven HWM; Hamberg P; Vulink AJE; Los M; Zwinderman AH; Ferwerda B; Lolkema MPJK; Steeghs N; Büller HR; Kamphuisen PW; van Es N
J Thromb Haemost; 2021 Dec; 19(12):2974-2983. PubMed ID: 34409743
[TBL] [Abstract][Full Text] [Related]
6. Comparison of risk prediction scores for cancer-associated thrombosis in ambulatory cancer patients not receiving thromboprophylaxis: A prospective cohort study in a South-East Asian population.
Thipbumrung S; Niprapan P; Suprasert P; Ketpueak T; Tantiworawit A; Punnachet T; Hantrakun N; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Rattarittamrong E; Norasetthada L; Chai-Adisaksopha C
Thromb Res; 2023 Dec; 232():138-144. PubMed ID: 37979462
[TBL] [Abstract][Full Text] [Related]
7. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.
Pabinger I; van Es N; Heinze G; Posch F; Riedl J; Reitter EM; Di Nisio M; Cesarman-Maus G; Kraaijpoel N; Zielinski CC; Büller HR; Ay C
Lancet Haematol; 2018 Jul; 5(7):e289-e298. PubMed ID: 29885940
[TBL] [Abstract][Full Text] [Related]
8. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
[TBL] [Abstract][Full Text] [Related]
9. Estimating Venous Thromboembolism Risk in Metastatic Colorectal Cancer Inpatients: Validation of Existing Risk Scores and Development of New Risk Scores.
Qin L; Liang Z; Xie J; Li X
Clin Appl Thromb Hemost; 2023; 29():10760296231196859. PubMed ID: 37691565
[TBL] [Abstract][Full Text] [Related]
10. Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.
Pelletier R
J Oncol Pharm Pract; 2021 Jun; 27(4):911-918. PubMed ID: 33757321
[TBL] [Abstract][Full Text] [Related]
11. Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.
Verzeroli C; Giaccherini C; Russo L; Bolognini S; Gamba S; Tartari CJ; Schieppati F; Ticozzi C; Vignoli A; Masci G; Sarmiento R; Spinelli D; Malighetti P; Tondini C; Petrelli F; Giuliani F; D'Alessio A; Gasparini G; Minelli M; De Braud F; Santoro A; Labianca R; Marchetti M; Falanga A;
J Thromb Haemost; 2023 Jul; 21(7):1869-1881. PubMed ID: 37054917
[TBL] [Abstract][Full Text] [Related]
12. [Predicting the Incidence of Venous Thromboembolism Using the Khorana Score: A Literature Review].
Nishimura A; Ikeda Y
Yakugaku Zasshi; 2021; 141(4):611-622. PubMed ID: 33790126
[TBL] [Abstract][Full Text] [Related]
13. The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study.
Overvad TF; Skjøth F; Piazza G; Noble S; Ording AG; Larsen TB; Nielsen PB
J Thromb Haemost; 2022 Dec; 20(12):2921-2929. PubMed ID: 36112135
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
[TBL] [Abstract][Full Text] [Related]
15. Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; Newman P; Mortazavi R
Thromb Res; 2024 Feb; 234():120-133. PubMed ID: 38215613
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic venous thromboembolism uncommon without thromboprophylaxis after isolated lower-limb fracture: the knee-to-ankle fracture (KAF) cohort study.
Selby R; Geerts WH; Kreder HJ; Crowther MA; Kaus L; Sealey F
J Bone Joint Surg Am; 2014 May; 96(10):e83. PubMed ID: 24875035
[TBL] [Abstract][Full Text] [Related]
17. Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study.
Dickmann B; Ahlbrecht J; Ay C; Dunkler D; Thaler J; Scheithauer W; Quehenberger P; Zielinski C; Pabinger I
Haematologica; 2013 Aug; 98(8):1309-14. PubMed ID: 23585523
[TBL] [Abstract][Full Text] [Related]
18. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis.
Mulder FI; Candeloro M; Kamphuisen PW; Di Nisio M; Bossuyt PM; Guman N; Smit K; Büller HR; van Es N;
Haematologica; 2019 Jun; 104(6):1277-1287. PubMed ID: 30606788
[TBL] [Abstract][Full Text] [Related]
19. Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study.
Cella CA; Di Minno G; Carlomagno C; Arcopinto M; Cerbone AM; Matano E; Tufano A; Lordick F; De Simone B; Muehlberg KS; Bruzzese D; Attademo L; Arturo C; Sodano M; Moretto R; La Fata E; De Placido S
Oncologist; 2017 May; 22(5):601-608. PubMed ID: 28424324
[TBL] [Abstract][Full Text] [Related]
20. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Ferrante N; De Tursi M; Iacobelli S; Cuccurullo F; Büller HR; Feragalli B; Porreca E
Thromb Haemost; 2010 Nov; 104(5):1049-54. PubMed ID: 20806119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
